Emerging therapeutic options for managing diabetic kidney disease.
作者信息
Walther Carl P, Whaley-Connell Adam, Navaneethan Sankar D
机构信息
aSection of Nephrology, Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, Texas bDivisions of Nephrology and Hypertension and Endocrinology and Metabolism, Department of Medicine, Research Service, Harry S Truman Memorial Veterans Hospital, University of Missouri-Columbia School of Medicine, Columbia, Missouri cSection of Nephrology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
出版信息
Curr Opin Nephrol Hypertens. 2017 Sep;26(5):335-337. doi: 10.1097/MNH.0000000000000345.
PMID:28548994
Abstract
摘要
相似文献
1
Emerging therapeutic options for managing diabetic kidney disease.糖尿病肾病管理的新兴治疗选择。
Curr Opin Nephrol Hypertens. 2017 Sep;26(5):335-337. doi: 10.1097/MNH.0000000000000345.
2
Early diabetic nephropathy. Emerging treatment options.早期糖尿病肾病。新出现的治疗选择。
Arch Intern Med. 1994 Mar 28;154(6):625-30.
3
Recent advances in managing and understanding diabetic nephropathy.糖尿病肾病管理与认识的最新进展
F1000Res. 2016 May 31;5. doi: 10.12688/f1000research.7693.1. eCollection 2016.
4
Emerging drugs for managing kidney disease in patients with diabetes.治疗糖尿病肾病的新兴药物。
Expert Opin Emerg Drugs. 2013 Mar;18(1):55-70. doi: 10.1517/14728214.2013.762356. Epub 2013 Jan 21.
5
Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.阿托伐他汀通过减轻糖尿病大鼠肾脏相关代谢紊乱发挥肾保护作用。
Eur J Pharmacol. 2014 Oct 5;740:9-14. doi: 10.1016/j.ejphar.2014.06.055. Epub 2014 Jul 5.
6
Bone morphogenetic protein-7 and Gremlin: New emerging therapeutic targets for diabetic nephropathy.骨形态发生蛋白-7与Gremlin：糖尿病肾病新出现的治疗靶点
Biochem Biophys Res Commun. 2009 May 22;383(1):1-3. doi: 10.1016/j.bbrc.2009.03.086. Epub 2009 Mar 19.
7
AGE-RAGE and AGE Cross-link interaction: important players in the pathogenesis of diabetic kidney disease.晚期糖基化终末产物受体（AGE-RAGE）与晚期糖基化终末产物交联相互作用：糖尿病肾病发病机制中的重要因素。
Horm Metab Res. 2005 Apr;37 Suppl 1:26-34. doi: 10.1055/s-2005-861360.
8
Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease.Roux-en-Y胃旁路术后代谢环境的改善与糖尿病肾病的缓解
Exp Physiol. 2014 Sep;99(9):1146-53. doi: 10.1113/expphysiol.2014.078790. Epub 2014 Aug 1.
9
Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease.挑战糖尿病肾病中线粒体活性氧过度产生的教条。
Kidney Int. 2016 Aug;90(2):272-279. doi: 10.1016/j.kint.2016.02.043. Epub 2016 May 20.
10
Bone disease in kidney transplant patients.肾移植患者的骨病
Semin Nephrol. 2009 Mar;29(2):166-73. doi: 10.1016/j.semnephrol.2009.01.009.
引用本文的文献
1
Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk.补充ω-3脂肪酸（鱼油）与蛋白尿：并非轻而易举之事。
J Am Heart Assoc. 2017 Jul 14;6(7):e006020. doi: 10.1161/JAHA.117.006020.
Zotero 插件